On November 14, 2024, Gail Marcus, Director at Natera Inc (NTRA, Financial), sold 2,212 shares of the company. The transaction was filed on November 15, 2024, as reported in the SEC Filing. Following this transaction, the insider now owns 19,386 shares of Natera Inc.
Natera Inc specializes in genetic testing and diagnostics with a focus on prenatal, neonatal, and cancer testing solutions. The company's innovative technologies provide detailed genetic information that assists healthcare providers in making informed decisions.
Over the past year, Gail Marcus has sold a total of 5,712 shares of Natera Inc and has not made any purchases of the stock. This recent sale is part of a broader trend observed within the company, where there have been 112 insider sells and no insider buys over the past year.
Shares of Natera Inc were trading at $158.53 on the day of the transaction. The company has a market cap of approximately $19.28 billion. According to the GF Value, the intrinsic value estimate for Natera Inc is $79.16, indicating that the stock is significantly overvalued with a price-to-GF-Value ratio of 2.
The GF Value is determined by considering historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This insider sale might be of interest to investors tracking insider behaviors and evaluating the valuation metrics of Natera Inc as it provides insights into both insider confidence and stock valuation levels.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
